AI assistant
Sending…
ETHZilla Corp — Director's Dealing 2021
Apr 9, 2021
33039_dirs_2021-04-09_bd30187b-93f6-4b19-b2fe-2368e8a99169.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: 180 Life Sciences Corp. (ATNF)
CIK: 0001690080
Period of Report: 2021-04-07
Reporting Person: Feldmann Marc (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2021-04-07 | Common Stock | A | 20910 | $6.14 | Acquired | 2617758 | Direct |
Footnotes
F1: Issued in consideration for accrued compensation due for services rendered as Co-Executive Chairman of the Issuer. Granted under the registrant's 2020 Omnibus Incentive Plan. Exempt from Section 16(b) pursuant to Rule 16b-3.
More from ETHZilla Corp
Interim / Quarterly Report
2026
May 15
Regulatory Filings
2026
May 14
Regulatory Filings
2026
Apr 29
Regulatory Filings
2026
Apr 17
Regulatory Filings
2026
Apr 8
Regulatory Filings
2026
Apr 8
Regulatory Filings
2026
Apr 8
Regulatory Filings
2026
Apr 3
Regulatory Filings
2026
Feb 26
Director's Dealing
2026
Feb 20